Comparison of outcomes for Hispanic and non‐Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database
Kripa Guram(University of California San Diego), Rana R. McKay(University of California San Diego), José Manuel Ruiz Morales(Hospital Médica Sur), Aaron R. Hansen(Princess Margaret Cancer Centre), Talal El Zarif(Yale University), Chinmay Jani(Mount Auburn Hospital), Vishal Navani(Hunter Medical Research Institute), Georges Gebrael(University of Utah), Nour Abdallah(Cleveland Clinic), Brent S. Rose(University of San Diego), Toni K. Choueiri(Harvard University), Elio Adib(Dana-Farber Brigham Cancer Center), Wanling Xie(Dana-Farber Cancer Institute), Muhieddine Labban(Brigham and Women's Hospital), Abhenil Mittal(Princess Margaret Cancer Centre), Haoran Li(General Hospital of Shenyang Military Region), Jiaming Huang(Dana-Farber Cancer Institute), Neeraj Agarwal(University of Utah), Chris Labaki(Beth Israel Deaconess Medical Center), Daniel Yick Chin Heng(University of Calgary), Christian Mouchati(University School)
Cited by 3
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k